Amgen 20140444: A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-Group Study toEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-inducedOsteoporosis

Project: Research project

Project Details

Description

Amgen 20140444: A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis
StatusActive
Effective start/end date8/1/187/31/22

Funding

  • Amgen Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.